Skip to main content
Elif Oral, MD, Endocrinology, Ann Arbor, MI

ElifOralMD

Endocrinology Ann Arbor, MI

Diabetes, Lipid Metabolism

Endocrinologist, Metabolism Endocrinology Diabetes & Podiatry Clinic

Dr. Oral is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Oral's full profile

Already have an account?

  • Office

    24 Frank Lloyd Wright Dr
    Lobby C Suite 1300
    Ann Arbor, MI 48105
    Phone+1 734-998-2450

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1993 - 1996
  • Istanbul University Fom
    Istanbul University FomClass of 1992

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1993 - 2027
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy  
    Elif A Oral, Nazanene H Esfandiari, Colleen M Buda, Corey J Lager, Oliver A Varban, Andrew T Kraftson, Obesity Surgery

Press Mentions

  • New Potential Therapy for Fatty Liver Disease
    New Potential Therapy for Fatty Liver DiseaseJune 7th, 2021
  • Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
    Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLDAugust 10th, 2018
  • Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018
    Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018March 17th, 2018
  • Join now to see all

Professional Memberships